Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the Best Conservative Stocks to Buy Right Now. On March 24, the company announced that it had completed the acquisition of Clario Holdings, Inc. The consideration included $8.875 billion in cash, along with potential additional earnout as well as other payments. These are mainly dependent on performance. The Clario business is now set to be a part of Thermo Fisher Scientific Inc. (NYSE:TMO)’s Laboratory Products and Biopharma Services segment.

The financial profile of Clario remains attractive, while the synergy realization makes returns compelling with a double-digit IRR. Notably, the company’s business is expected to see growth in the high single digits and can contribute $0.45 of adjusted EPS in the first year post-close. The business is also accretive to the adjusted operating margin of Thermo Fisher Scientific Inc. (NYSE:TMO).

Thermo Fisher Scientific Inc. (NYSE:TMO) anticipates realizing ~$175 million of adjusted operating income from synergies by year 5 after the close. This is expected mainly from revenue synergies, which will come from combined capabilities.

Thermo Fisher Scientific Inc. (NYSE:TMO) offers more than 2 million products and services for pharmaceutical development, biotechnology research, clinical diagnostics, as well as laboratory management.

While we acknowledge the risk and potential of TMO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TMO and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best FMCG Stocks to Invest In According to Analysts and 11 Best Long-Term Tech Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey on Google News.